These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17958347)

  • 41. QSAR study of PETT derivatives as potent HIV-1 reverse transcriptase inhibitors.
    Sabet R; Fassihi A; Moeinifard B
    J Mol Graph Model; 2009 Sep; 28(2):146-55. PubMed ID: 19570701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation.
    Tang H; Wang XS; Huang XP; Roth BL; Butler KV; Kozikowski AP; Jung M; Tropsha A
    J Chem Inf Model; 2009 Feb; 49(2):461-76. PubMed ID: 19182860
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison data sets for benchmarking QSAR methodologies in lead optimization.
    Mittal RR; McKinnon RA; Sorich MJ
    J Chem Inf Model; 2009 Jul; 49(7):1810-20. PubMed ID: 19569715
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determination and prediction of xenoestrogens by recombinant yeast-based assay and QSAR.
    Li F; Chen J; Wang Z; Li J; Qiao X
    Chemosphere; 2009 Mar; 74(9):1152-7. PubMed ID: 19136139
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of quantitative structural analysis to predict fish bioconcentration factors for pesticides.
    Jackson SH; Cowan-Ellsberry CE; Thomas G
    J Agric Food Chem; 2009 Feb; 57(3):958-67. PubMed ID: 19138085
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Understanding the toxicity of phenols: using quantitative structure-activity relationship and enthalpy changes to discriminate between possible mechanisms.
    Shadnia H; Wright JS
    Chem Res Toxicol; 2008 Jun; 21(6):1197-204. PubMed ID: 18500785
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antioxidant QSAR modeling as exemplified on polyphenols.
    Lucić B; Amić D; Trinajstić N
    Methods Mol Biol; 2008; 477():207-18. PubMed ID: 19082949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LQTA-QSAR: a new 4D-QSAR methodology.
    Martins JP; Barbosa EG; Pasqualoto KF; Ferreira MM
    J Chem Inf Model; 2009 Jun; 49(6):1428-36. PubMed ID: 19422246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 3D and quantum QSAR of non-benzodiazepine compounds.
    Pasha FA; Muddassar M; Cho SJ; Ahmad K; Beg Y
    Eur J Med Chem; 2008 Nov; 43(11):2361-72. PubMed ID: 18346822
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bioactivities of a series of phosphodiesterase type 5 (PDE-5) inhibitors as modelled by MIA-QSAR.
    Antunes JE; Freitas MP; Rittner R
    Eur J Med Chem; 2008 Aug; 43(8):1632-8. PubMed ID: 18045743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. From Wiener index to molecules.
    Cerruela García G; Luque Ruiz I; Gómez-Nieto MA; Cabrero Doncel JA; Guevara Plaza A
    J Chem Inf Model; 2005; 45(2):231-8. PubMed ID: 15807483
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exploring QSAR for substituted 2-sulfonyl-phenyl-indol derivatives as potent and selective COX-2 inhibitors using different chemometrics tools.
    Khoshneviszadeh M; Edraki N; Miri R; Hemmateenejad B
    Chem Biol Drug Des; 2008 Dec; 72(6):564-74. PubMed ID: 19090923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative structure-activity relationship (QSAR) for a series of novel cannabinoid derivatives using descriptors derived from semi-empirical quantum-chemical calculations.
    Ferreira AM; Krishnamurthy M; Moore BM; Finkelstein D; Bashford D
    Bioorg Med Chem; 2009 Mar; 17(6):2598-606. PubMed ID: 19250829
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structural analysis of carboline derivatives as inhibitors of MAPKAP K2 using 3D QSAR and docking studies.
    Nayana RS; Bommisetty SK; Singh K; Bairy SK; Nunna S; Pramod A; Muttineni R
    J Chem Inf Model; 2009 Jan; 49(1):53-67. PubMed ID: 19119997
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Linear and nonlinear 3D-QSAR approaches in tandem with ligand-based homology modeling as a computational strategy to depict the pyrazolo-triazolo-pyrimidine antagonists binding site of the human adenosine A2A receptor.
    Michielan L; Bacilieri M; Schiesaro A; Bolcato C; Pastorin G; Spalluto G; Cacciari B; Klotz KN; Kaseda C; Moro S
    J Chem Inf Model; 2008 Feb; 48(2):350-63. PubMed ID: 18215030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potential glucocorticoid receptor ligands with pulmonary selectivity using I-QSAR with the signature molecular descriptor.
    Jackson JD; Weis DC; Visco DP
    Chem Biol Drug Des; 2008 Dec; 72(6):540-50. PubMed ID: 19090921
    [TBL] [Abstract][Full Text] [Related]  

  • 57. QSAR modeling of the antifungal activity against Candida albicans for a diverse set of organic compounds.
    Katritzky AR; Slavov SH; Dobchev DA; Karelson M
    Bioorg Med Chem; 2008 Jul; 16(14):7055-69. PubMed ID: 18550376
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predicting anti-HIV activity of 1,3,4-thiazolidinone derivatives: 3D-QSAR approach.
    Ravichandran V; Prashantha Kumar BR; Sankar S; Agrawal RK
    Eur J Med Chem; 2009 Mar; 44(3):1180-7. PubMed ID: 18687505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacophore and docking-based combined in-silico study of KDR inhibitors.
    Pasha FA; Muddassar M; Neaz MM; Cho SJ
    J Mol Graph Model; 2009 Aug; 28(1):54-61. PubMed ID: 19447057
    [TBL] [Abstract][Full Text] [Related]  

  • 60. QSAR models for predicting enzymatic hydrolysis of new chemical entities in 'soft-drug' design.
    Massarelli I; Macchia M; Minutolo F; Prota G; Bianucci AM
    Bioorg Med Chem; 2009 May; 17(10):3543-56. PubMed ID: 19398207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.